InMed Conferences and Events
Edison Open House: Global Conference 2021
Date: January 26-28, 2021
Conference website: https://www.edisongroup.com/event/open-house-global-healthcare-2021/
Presentation details: InMed’s CEO Eric A. Adams to present Thursday, January 28th at 1:30pm GMT / 8:30am EST. Presentation information available here.
For 1×1 meetings, please reach out to Laine Yonker at [email protected].
Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe
Date: January 19-21, 2021
Conference website: https://cdp-europe.com/
Panel participation details:
InMed’s Michael Woudenberg – Vice President, Chemistry, Manufacturing & Controls, Karen Long – Senior Director, Drug Development, and Prof. Mauro Maccarrone PhD – Scientific Advisor to InMed will all be featured as expert speakers at the event.
Mr. Michael Woudenberg will participate on the panel discussion “Comparing Whole Plant & Synthetic Cannabinoids & Their Potential in Pharmaceuticals” on January 20, 2021 at 12:00pm GMT.
Ms. Karen Long will participate on the panel discussion “The Industry Approach to Gaining Drug Approval” on January 20, 2021 at 2:30pm GMT.
In addition, Prof. Mauro Maccarrone, a member of InMed’s Scientific Advisory Board, will speak in a lecture entitled “Plant-Derived & Endogenous Cannabinoids: Naturally Different”.
H. C. Wainwright BioConnect 2021
InMed CEO Eric A. Adams to present at H. C. Wainwright BioConnect 2021.
Date: January 11-14, 2021
Conference Website: www.hcwevents.com/bioconnect.
Presentation Details: The company presentation by Eric A. Adams, President and CEO of InMed, will be available on demand beginning January 11th at 6am EST and can be found at the below link. The presentation will be archived for 90 days following the conclusion of the event. Presentation Link: https://journey.ct.events/view/a48c3f9e-1802-4279-95ca-eff84fafe024